Evidence map›Paper›PMID 41174009›Full record

ArticleNature biomedical engineering2026

Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer.

Junjie Li, Kazuko Toh, Panyue Wen, Xueying Liu, Anjaneyulu Dirisala, Haochen Guo, Joachim F R Van Guyse, Saed Abbasi, Yasutaka Anraku, Yuki Mochida and 4 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Junjie LiInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan. junjie_li@ms.ifoc.kyushu-u.ac.jp.ORCID http://orcid.org/0000-0002-4862-2517
Kazuko TohInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan.
Panyue WenInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan.ORCID http://orcid.org/0009-0007-7761-4165
Xueying LiuInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan.
Anjaneyulu DirisalaInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan.ORCID http://orcid.org/0000-0003-1566-7142
Haochen GuoInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan.
Joachim F R Van GuyseInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan.ORCID http://orcid.org/0000-0001-5725-6531
Saed AbbasiInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan.ORCID http://orcid.org/0000-0001-8874-233X
Yasutaka AnrakuInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan.
Yuki MochidaInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan.ORCID http://orcid.org/0000-0002-5559-8519
Hiroaki KinohInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan.ORCID http://orcid.org/0000-0002-5859-0942
Horacio CabralDepartment of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-4030-2631
Masaru TanakaInstitute for Materials Chemistry and Engineering, Kyushu University, Fukuoka, Japan.ORCID http://orcid.org/0000-0002-1115-2080
Kazunori KataokaInnovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan. kkataoka@g.ecc.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-8591-413X

Funding

MEXT | Japan Science and Technology Agency (JST) JPMJPF2202MEXT | Japan Society for the Promotion of Science (JSPS) 20K20209MEXT | Japan Society for the Promotion of Science (JSPS) 23H03740MEXT | Japan Society for the Promotion of Science (JSPS) P17356
6 · The paper itself

Abstract

The high interfacial energy of nanomaterials limits their certain biomedical applications that require stealthiness to minimize non-specific interaction with biological components. While steric repulsion-based entropic stabilization-such as PEGylation-has long been the dominant strategy for designing stealth nanomaterials, its inherent softness and susceptibility to dynamic deformation and external forces often result in only moderate stealth performance. Here we report a distinct approach to achieving stealthiness by harnessing an ion-pair network, rather than maximizing steric repulsion. Using model polyion complex nanoparticles composed of equimolar charge ratios of polycations and polyanions, we demonstrate that increasing crosslinks between the constituent polyions beyond a critical threshold effectively reduces protein adsorption and macrophage uptake, enabling prolonged circulation with a half-life exceeding 100 hours. Building on this, we develop an asparaginase-loaded vesicular nanoreactor enveloped by a semi-permeable ion-pair network sheath for asparagine starvation therapy. The extended circulation of these nanoreactors enables sustained depletion of asparagine, leading to improved therapeutic outcomes for metastatic breast and pancreatic cancers. Our findings open an avenue for improving the pharmacokinetics of nanomaterials for therapeutic delivery through delicately engineering stable intermolecular structures with holistic cooperativity.

Indexed as

NanoparticlesNanostructuresNeoplasmsAnimalsAsparaginaseAsparagineCell Line, TumorHumansMiceAsparaginaseAsparagine

Identifiers

PMID41174009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.